Ardelyx reported $732K in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US USD 2K 21K
Abbott ABT:US USD 4.63B 304M
Amgen AMGN:US USD 1.59B 78M
Ardelyx ARDX:US USD 732K 594K
Astrazeneca AZN:US USD 2.12B 214M
Biocept BIOC:US USD 5.78M 2.25M
Chimerix CMRX:US USD 333K 333K
Corcept Therapeutics CORT:US USD 1.34M 23K
Curis CRIS:US USD 62K 20K
Opko Health OPK:US USD 148.44M 45.87M
United Therapeutics UTHR:US USD 37.2M 7.5M